Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/16/20
End: 04/05/24
Due: 04/05/25
Phase: N/A
Priority: Normal
Start: 03/30/23
End: 06/30/24
Due: 06/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors | NCT04190628 | ABM Therapeutics Corporation | user2@example.com | None | 2020-06-16 | 2024-04-05 | 2025-04-05 | - | - | 2025-07-14 |
| Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors. | NCT05831995 | ABM Therapeutics Corporation | user2@example.com | None | 2023-03-30 | 2024-06-30 | 2025-06-30 | - | - | 2025-07-14 |